Siddiqi, Ahmed Kamal http://orcid.org/0000-0001-5612-8626
Maniya, Muhammad Talha
Alam, Muhammad Tanveer
Ambrosy, Andrew P.
Fudim, Marat
Greene, Stephen J.
Khan, Muhammad Shahzeb
Article History
Accepted: 29 January 2024
First Online: 28 February 2024
Declarations
:
: No external funding was used in this work.
: All data generated or analysed during this study are included in this published article (and its supplementary information files).
: N/A.
: All authors participated in data curation, analysis, writing, reviewing and editing this manuscript.
: A.P.A. is supported by a grant from the National Heart, Lung, and Blood Institute (K23HL150159), American Heart Association (no. 1155554), has received relevant research support through grants to his institution from Amarin Pharma, Inc., Abbott, and Novartis, and modest reimbursement for travel from Novartis. Dr. Greene has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association (no. 929502), Amgen, AstraZeneca, Boehinger Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards or as consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim/ Lilly, Bristol Myers Squibb, Corteria Pharmaceuticals, CSL Vifor, Cytokinetics, Lexicon, Merck, Roche Diagnostics, Sanofi, scPharmaceuticals, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from Boehringer Ingelheim, Cytokinetics, Lexicon, and Roche Diagnostics. M.F. is supported by the Mario Family Award, Duke Chair’s Award, Translating Duke Health Award, Bayer, and BTG Specialty Pharmaceuticals. He receives consulting fees from AxonTherapies, Bodyport, CVRx, Daxor, Edwards LifeSciences, Fire1, NXT Biomedical, Zoll, and Viscardia. S.J.G. has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association (no. 929502), National Heart Lung and Blood Institute, Amgen, AstraZeneca, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards for Amgen, AstraZeneca, Boehringer Ingelheim/ Lilly, Bristol Myers Squibb, Cytokinetics, Roche Diagnostics, Sanofi, and scPharmaceuticals; serves as a consultant for Amgen, Bayer, Bristol Myers Squibb, Boehringer Ingelheim/ Lilly, CSL Vifor, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from Boehringer Ingelheim and Cytokinetics.
: N/A.
: N/A.
: N/A.